# Oral Dosage Form New Animal Drugs; Sulfadiazine/Pyrimethamine Suspension
> **Food and Drug Administration** · Final rule. · Published 2008-09-17 · Effective 2008-09-17 · 73 FR 53685
## Document
- **Document number:** E8-21625
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 73 FR 53685
- **CFR reference:** 21 CFR 520
- **Publication date:** 2008-09-17
- **Effective date:** 2008-09-17
- **HHS docket:** Docket No. FDA-2008-N-0039
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Animal Health Pharmaceuticals, LLC. The supplemental NADA provides for a revised human food safety warning on labeling for an oral suspension of sulfadiazine and pyrimethamine used for the treatment of equine protozoal myeloencephalitis (EPM).

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2008/09/17/E8-21625/oral-dosage-form-new-animal-drugs-sulfadiazinepyrimethamine-suspension)
---
*AI Analytics · CC0 1.0*